A US Drug Master File (US DMF) is a confidential regulatory submission to the US FDA that provides detailed information about the manufacturing process, controls, facilities, and quality systems for pharmaceutical substances and materials. Our US DMF Listing and Submission services help manufacturers prepare, submit, and maintain FDA-compliant DMFs that support ANDA, NDA, and IND applications.
We deliver accurate, complete, and inspection-ready US DMFs to enable smooth regulatory reviews and long-term compliance.
End-to-End US DMF Services
Our services cover the complete DMF lifecycle—from initial strategy and listing to post-submission maintenance and FDA query support.
Scope of US DMF Listing & Submission Services
- US DMF Strategy & Regulatory Planning
- DMF type identification (Type II, III, IV, V)
- Regulatory pathway and submission strategy
- Gap assessment against current US FDA requirements
- Readiness assessment of manufacturing sites and data
- US DMF Preparation & Compilation
- Complete DMF dossier preparation in CTD format
- Manufacturing process description and flow diagrams
- Control of materials, impurities, and residual solvents
- Specifications, analytical methods, and validation data
- FDA DMF Listing & Submission
- Electronic submission via FDA ESG
- DMF number assignment and confirmation
- Technical completeness and compliance checks
- eCTD-ready documentation support
- Letter of Authorization (LoA) Management
- Preparation and submission of Letters of Authorization
- Cross-referencing support for ANDA/NDA applicants
- Coordination with customers and regulatory teams
- Deficiency Response & Lifecycle Management
- FDA information request and deficiency response
- Annual updates and amendments
- Change control and post-approval submissions
- Support during FDA inspections and audits
Regulatory Standards & Guidelines Covered
Our US DMF services are aligned with:
- US FDA DMF Guidance
- 21 CFR Parts 210 & 211
- ICH Q7 (API GMP)
- ICH Q1, Q2, Q3, Q6
- Data Integrity & cGMP Requirements
- eCTD & ESG Submission Standards
This ensures acceptance across US regulatory and customer applications.
Risk-Based & Regulator-Focused Approach
We follow a science-driven, risk-based approach focused on impurity control, process robustness, data integrity, and regulatory clarity—key areas evaluated during FDA DMF reviews and inspections.
Key Deliverables
- FDA-compliant US DMF dossier
- DMF listing and submission confirmation
- Letters of Authorization (LoA)
- Deficiency response packages
- Inspection-ready technical documentation
Why Choose Our US DMF Listing & Submission Services?
- US FDA Regulatory Expertise
Strong understanding of FDA DMF expectations and review practices. - High-Quality Technical Writing
Clear, concise, and reviewer-friendly DMFs. - Inspection-Ready Submissions
Prepared with FDA audit and inspection perspectives. - End-to-End Lifecycle Support
From DMF listing to annual updates and amendments. - Confidential & Secure Data Handling
Strict control of proprietary technical information.
Industries We Support
- API Manufacturers
- Pharmaceutical Intermediates Manufacturers
- Excipient Manufacturers
- Contract Manufacturing Organizations (CMOs)
- Export-Oriented Pharmaceutical Companies
- Start-ups and New API Facilities
Enter the US Market with Confidence
With increasing FDA scrutiny on API quality, impurity control, and data integrity, a well-prepared US DMF is essential for regulatory success. Our structured and regulator-aligned approach helps ensure faster acceptance, fewer deficiencies, and sustained compliance.
